GlassScriptPhysician profile
Neil Stuart Roth
NPI 1689606998
$8,591.00
in general payments reported to CMS, 2019-2025
11 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $29.44 · 2021: $14.19 · 2022: $193 · 2023: $2,366 · 2024: $4,983 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,944 · Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,943.54 |
| Food and Beverage | $1,270.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $6,959.10 | 2023-2025 | |
| Lazurite INC. | $514.75 | 2023 | |
| Depuy Synthes Sales INC. | $492.26 | 2019-2025 | Dynacord, Milagro, Attune |
| Ferring Pharmaceuticals INC. | $287.29 | 2020-2025 | Euflexxa |
| Smith+Nephew, INC. | $115.76 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System |
| Dynasplint Systems INC. | $88.63 | 2019 | |
| Stryker Corporation | $38.12 | 2019 | |
| Bioventus LLC | $32.06 | 2024 | Durolane |
| Electronic Waveform Lab, INC. | $27.68 | 2023 | |
| Fidia Pharma USA INC. | $20.48 | 2023 | Hymovis, Triluron |
| Boston Scientific Corporation | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,634,222.85 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.